LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Mau, Yi-Chien"
  2. AU="Lucas, Dominique N"
  3. AU="Aaliya Minhaz"
  4. AU=Jahn Katharina
  5. AU="Krach, Sören"
  6. AU="Bower, Hilary"
  7. AU="Kansakar, Prerana"
  8. AU="McCullagh, Elizabeth A"
  9. AU="Pereira, Ivanio Alves"
  10. AU="Singh, Rupinder"
  11. AU="Leung, Cheuk Lun"
  12. AU=Berman Claudia G
  13. AU=Chang Wen Xiu
  14. AU=Chen Jianchun
  15. AU="Zhou, Long" AU="Zhou, Long"
  16. AU=Bauer Michael AU=Bauer Michael
  17. AU=Clapp Benjamin
  18. AU="Makarenko, V"
  19. AU="Stahl, Anna"
  20. AU="Wa, Qingbo"
  21. AU="Annette T. Byrne"
  22. AU="Godwin Oligbu"

Suchergebnis

Treffer 1 - 5 von insgesamt 5

Suchoptionen

  1. Artikel: The role of BRCA1 in non-homologous end-joining.

    Bau, Da-Tian / Mau, Yi-Chien / Shen, Chen-Yang

    Cancer letters

    2005  Band 240, Heft 1, Seite(n) 1–8

    Abstract: From the genotypic viewpoint, single nucleotide polymorphisms in the genes of the non-homologous end-joining (NHEJ) pathway, which is important in the repair of DNA double-strand breaks, have been shown to be associated with increased breast cancer risk. ...

    Abstract From the genotypic viewpoint, single nucleotide polymorphisms in the genes of the non-homologous end-joining (NHEJ) pathway, which is important in the repair of DNA double-strand breaks, have been shown to be associated with increased breast cancer risk. However, more phenotypic evidence is needed to strengthen the link between defective NHEJ genes and breast cancer development. Recently, BRCA1-deficient mouse embryonic fibroblasts were found to have significantly reduced NHEJ activity, suggesting an accessory role of BRCA1 in NHEJ. Since BRCA1 is a well-documented breast cancer susceptibility gene, this association between NHEJ and BRCA1 not only suggests a role of BRCA1 in NHEJ, but also provides support for the tumorigenic contribution of the NHEJ pathway to breast cancer development. Interestingly, the phenotypic data show that BRCA1 may promote only specific subtypes of NHEJ, e.g. in vivo precise and terminal end-joining capacities, and have either a suppressive or no effect on others. However, these findings have remained inconclusive, and the lack of consistency between these results may be at least partly explained by the use of different assays, which may measure different subtypes of NHEJ, and of different cell lines investigated. Although some insights have been obtained, the whole picture of NHEJ repair in mammalian cells is far from complete, and the questions of how many subpathways are involved or how we can investigate each subpathway have not yet been adequately addressed.
    Mesh-Begriff(e) Acid Anhydride Hydrolases ; Animals ; BRCA1 Protein/genetics ; BRCA1 Protein/metabolism ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Cell Cycle Proteins/metabolism ; DNA Repair ; DNA Repair Enzymes/metabolism ; DNA-Binding Proteins/metabolism ; Genetic Predisposition to Disease ; Genetic Techniques ; Humans ; MRE11 Homologue Protein ; Nuclear Proteins/metabolism ; Polymorphism, Single Nucleotide ; Recombination, Genetic
    Chemische Substanzen BRCA1 Protein ; Cell Cycle Proteins ; DNA-Binding Proteins ; MRE11 protein, human ; Mre11a protein, mouse ; NBN protein, human ; Nuclear Proteins ; MRE11 Homologue Protein (EC 3.1.-) ; Acid Anhydride Hydrolases (EC 3.6.-) ; RAD50 protein, human (EC 3.6.-) ; DNA Repair Enzymes (EC 6.5.1.-)
    Sprache Englisch
    Erscheinungsdatum 2005-09-19
    Erscheinungsland Ireland
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 195674-7
    ISSN 1872-7980 ; 0304-3835
    ISSN (online) 1872-7980
    ISSN 0304-3835
    DOI 10.1016/j.canlet.2005.08.003
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: DNA double-strand break repair capacity and risk of breast cancer.

    Bau, Da-Tian / Mau, Yi-Chien / Ding, Shian-Ling / Wu, Pei-Ei / Shen, Chen-Yang

    Carcinogenesis

    2007  Band 28, Heft 8, Seite(n) 1726–1730

    Abstract: A tumorigenic role of the non-homologous end-joining (NHEJ) pathway for the repair of DNA double-strand breaks (DSBs) has been suggested by our finding of a significant association between increased breast cancer risk and a cooperative effect of single- ... ...

    Abstract A tumorigenic role of the non-homologous end-joining (NHEJ) pathway for the repair of DNA double-strand breaks (DSBs) has been suggested by our finding of a significant association between increased breast cancer risk and a cooperative effect of single-nucleotide polymorphisms in NHEJ genes. To confirm this finding, this case-control study detected both in vivo and in vitro DNA end-joining (EJ) capacities in Epstein-Barr virus-immortalized peripheral blood mononuclear cells (PBMCs) of 112 breast cancer patients and 108 healthy controls to identify individual differences in EJ capacity to repair DSB as a risk factor predisposing women to breast cancer. PBMCs from breast cancer patients consistently showed lower values of in vivo and in vitro EJ capacities than those from healthy women (P < 0.05). Logistic regression, simultaneously considering the effect of known risk factors of breast cancer, shows that the in vitro EJ capacity above the median of control subjects was associated with nearly 3-fold increased risks for breast cancer (adjusted odds ratio, 2.98; 95% confidence interval, 1.64-5.43). Furthermore, a dose-response relationship was evident between risk for breast cancer and EJ capacity, which was analyzed as a continuous variable (every unit decrease of EJ capacity being associated with an 1.09-fold increase of breast cancer risk) and was divided into tertiles based on the EJ capacity values of the controls (P for trend < 0.01). The findings support the conclusion that NHEJ may play a role in susceptibility to breast cancer.
    Mesh-Begriff(e) Breast Neoplasms/genetics ; Case-Control Studies ; Cell Line, Transformed ; DNA Breaks, Double-Stranded ; DNA Repair/genetics ; Female ; Genetic Predisposition to Disease ; Humans ; Random Allocation ; Risk Factors
    Sprache Englisch
    Erscheinungsdatum 2007-08
    Erscheinungsland England
    Dokumenttyp Journal Article ; Validation Studies
    ZDB-ID 603134-1
    ISSN 1460-2180 ; 0143-3334
    ISSN (online) 1460-2180
    ISSN 0143-3334
    DOI 10.1093/carcin/bgm109
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel: Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.

    Lo, Yen-Li / Yu, Jyh-Cherng / Chen, Shou-Tung / Hsu, Giu-Cheng / Mau, Yi-Chien / Yang, Show-Lin / Wu, Pei-Ei / Shen, Chen-Yang

    Carcinogenesis

    2007  Band 28, Heft 5, Seite(n) 1079–1086

    Abstract: Aneuploidy occurs early during tumorigenesis and may contribute to tumor formation. Tumor cells become aneuploid as a result of aberrant mitotic divisions, suggesting a tumorigenic contribution of the mechanisms in maintaining chromosomal number ... ...

    Abstract Aneuploidy occurs early during tumorigenesis and may contribute to tumor formation. Tumor cells become aneuploid as a result of aberrant mitotic divisions, suggesting a tumorigenic contribution of the mechanisms in maintaining chromosomal number stability. We therefore speculated that the genes TTK, MAD2L1, BUB1, BUB1B and PTTG1 (Securin), jointly implicated in the regulation of mitotic checkpoint, might be associated with breast tumorigenesis. To test this hypothesis, this case-control study of 698 primary breast cancer patients and 1492 healthy controls examined single-nucleotide polymorphisms (SNPs) in these mitotic checkpoint genes to define their tumorigenic contribution. Because estrogen is known to promote breast cancer development via its mitogenic effect leading to malignant proliferation of breast epithelium and the mitotic checkpoint genes are involved in regulating mitosis, we were also interested in knowing whether any association between genotypes and breast cancer risk was modified by reproductive risk factors. Support for these hypotheses came from the observations that (i) two SNPs in TTK and PTTG1 were associated with breast cancer risk; (ii) haplotype and haplotype combination analyses in TTK, BUB1B and PTTG1 revealed a strong association with breast cancer risk; (iii) a trend to an increased risk of breast cancer was found in women harboring a greater number of putative high-risk genotypes/haplotypes of mitotic checkpoint genes and (iv) a significant interaction between high-risk genotypes/haplotypes and reproductive risk factors in determining breast cancer risk was defined. This study provides new support for the mutator role of mitotic checkpoint genes in breast cancer development, suggesting that breast cancer could be driven by genomic instability associated with variant mitotic checkpoint genes, the tumorigenic contribution of which could be enhanced as a result of increased mitosis due to estrogen exposure.
    Mesh-Begriff(e) Adult ; Breast Neoplasms/genetics ; Calcium-Binding Proteins/genetics ; Carcinoma, Ductal, Breast/genetics ; Case-Control Studies ; Cell Cycle Proteins/genetics ; Estrogens/genetics ; Female ; Genes, cdc ; Genetic Predisposition to Disease ; Genotype ; Humans ; Mad2 Proteins ; Middle Aged ; Neoplasm Proteins/genetics ; Polymorphism, Single Nucleotide ; Protein Kinases/genetics ; Protein-Serine-Threonine Kinases/genetics ; Protein-Tyrosine Kinases ; Repressor Proteins/genetics ; Risk Factors ; Securin
    Chemische Substanzen Calcium-Binding Proteins ; Cell Cycle Proteins ; Estrogens ; MAD2L1 protein, human ; Mad2 Proteins ; Neoplasm Proteins ; Repressor Proteins ; Securin ; pituitary tumor-transforming protein 1, human ; Protein Kinases (EC 2.7.-) ; Protein-Tyrosine Kinases (EC 2.7.10.1) ; BUB1 protein, human (EC 2.7.11.1) ; Bub1 spindle checkpoint protein (EC 2.7.11.1) ; Protein-Serine-Threonine Kinases (EC 2.7.11.1) ; TTK protein, human (EC 2.7.12.1)
    Sprache Englisch
    Erscheinungsdatum 2007-05
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 603134-1
    ISSN 1460-2180 ; 0143-3334
    ISSN (online) 1460-2180
    ISSN 0143-3334
    DOI 10.1093/carcin/bgl256
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.

    Lo, Yen-Li / Yu, Jyh-Cherng / Chen, Shou-Tung / Yang, Hsin-Chou / Fann, Cathy S J / Mau, Yi-Chien / Shen, Chen-Yang

    International journal of cancer

    2005  Band 115, Heft 2, Seite(n) 276–283

    Abstract: Aneuploidy, an abnormal number of chromosomes, is relatively common and occurs early in breast cancer development. This observation supports a breast tumorigenic contribution of mechanisms responsible for maintaining chromosome number stability in which ... ...

    Abstract Aneuploidy, an abnormal number of chromosomes, is relatively common and occurs early in breast cancer development. This observation supports a breast tumorigenic contribution of mechanisms responsible for maintaining chromosome number stability in which centrosomes play an essential role. We therefore speculated that the Aurora-A/STK15/BTAK gene, implicated in the regulation of centrosome duplication, may be associated with breast tumorigenesis. To test this hypothesis, we conducted a case-control study of 709 primary breast cancer patients and 1,972 healthy controls, examining single-nucleotide polymorphisms (SNPs), including a suggested functional Phe31Ile SNP, in Aurora-A. We were also interested in knowing whether any association between Aurora-A and breast cancer was modified by reproductive risk factors reflecting susceptibility to estrogen exposure. Our hypothesis is that, since estrogen is known to promote breast cancer development via its mitogenic effect leading to malignant proliferation on breast epithelium and since Aurora-A is involved in regulating mitosis, the discovery of a joint effect between the Aurora-A genotype and reproductive risk factors on cancer risk might yield valuable clues to the association of breast tumorigenesis with estrogen. Support for this hypothesis came from the following observations. (i) Two SNPs in Aurora-A were significantly associated with breast cancer risk (p < 0.05). (ii) Haplotype analyses, based on different combinations of multiple SNPs in Aurora-A, revealed a strong association with breast cancer risk; interestingly, the genotypic distribution of the suggested functional Phe31Ile SNP was not significantly different between breast cancer patients and controls, but the specific haplotype containing the putative at-risk Ile allele was more common in patients. (iii) This association between risk and putative high-risk genotypes was stronger and more significant in women thought to be more susceptible to estrogen, i.e., those with a longer interval between menarche and first full-term pregnancy. (iv) The protective effect conferred by a history of full-term pregnancy was significant only in women with a putative low-risk genotype of Aurora-A. Our study provides new findings supporting the mutator role of Aurora-A in breast cancer development, suggesting that breast cancer could be driven by genomic instability associated with variant Aurora-A, the tumorigenic contribution of which could be enhanced as a result of increased mitosis due to estrogen exposure.
    Mesh-Begriff(e) Aurora Kinase A ; Aurora Kinases ; Breast Neoplasms/enzymology ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Carcinoma, Ductal, Breast/enzymology ; Carcinoma, Ductal, Breast/genetics ; Carcinoma, Ductal, Breast/pathology ; Case-Control Studies ; Centrosome ; Estrogens/adverse effects ; Female ; Genetic Predisposition to Disease ; Genomic Instability ; Genotype ; Haplotypes/genetics ; Humans ; Menarche ; Mitosis ; Polymorphism, Single Nucleotide/genetics ; Pregnancy ; Protein-Serine-Threonine Kinases/genetics ; Risk Factors
    Chemische Substanzen Estrogens ; AURKA protein, human (EC 2.7.11.1) ; Aurora Kinase A (EC 2.7.11.1) ; Aurora Kinases (EC 2.7.11.1) ; Protein-Serine-Threonine Kinases (EC 2.7.11.1)
    Sprache Englisch
    Erscheinungsdatum 2005-06-10
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218257-9
    ISSN 1097-0215 ; 0020-7136
    ISSN (online) 1097-0215
    ISSN 0020-7136
    DOI 10.1002/ijc.20855
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Patterns of Circulating Hepatitis B Surface Antigen Variants among Vaccinated Children Born to Hepatitis B Surface Antigen Carrier and Non-Carrier Mothers

    Ho, Mei-Shang / Mau, Yi-Chien / Lu, Chih-Feng / Huang, Shiang-Fen / Hsu, Li-Ching / Lin, Sheue-Rong / Hsu, Hsu-Mei

    Journal of Biomedical Science

    1998  Band 5, Heft 5, Seite(n) 355–362

    Abstract: Hepatitis B virus (HBV) variants that possessed missense mutation within the neutralization epitope of the major S antigen as defined by amino acid residues (aa#) 124-147, termed the ‘a’ determinant variants, were identified through a population-based ... ...

    Körperschaft Division of Epidemiology & Public Health, Institute of Biomedical Sciences, Academia Sinica Graduate Institute of Epidemiology, School of Public Health, National Taiwan University National Institute of Preventive Medicine, Department of Health Bureau of Communicable Disease Control, Department of Health, Taipei, Taiwan, ROC
    Abstract Hepatitis B virus (HBV) variants that possessed missense mutation within the neutralization epitope of the major S antigen as defined by amino acid residues (aa#) 124-147, termed the ‘a’ determinant variants, were identified through a population-based serosurvey of 2,305 children of the vaccinated birth cohorts born after 1986. Data on the 678 nucleotides encoding the S antigen of HBV were available for 75 HBV strains that were collected from 63 vaccinated children and 12 unvaccinated or incompletely vaccinated children, and 21 HBV strains from 25 unvaccinated adults. Among the diverse patterns of one to three amino acid substitutions within the ‘a’ determinant, 145-Arg occurred most frequently (5/14); other variants were: 126-Ala, 127-Thr, 126-Ser/131-Asn/133-Thr, 129-His, 129-Arg, 123-Asn/131-Ile, 133-Leu, 141-Glu, and 141-Arg/144-Ala. Only one of these variants occurred in the 16 hepatitis B surface antigen (HBsAg)-carrier children born to HBsAg-negative mothers, whereas 12 of these variants occurred in the 20 (50%) children born to HBsAg-positive mothers. In addition, early administration of HBV vaccine within the noenatal period increased the likelihood of the emergence of these variants to 64.7% (11/17). Five of the 21 (23.8%) unvaccinated HBsAg-carrier adults harbored the ‘a’ determinant variants possessing mutations within aa# 125-136, i.e. the putative first loop formed by the cysteine disulfide bonds. Vaccinated children were likely to harbor HBV variants possessing mutations involving altered charge of side chains and/or its hydrophobicity of amino acid residues within the putative second loop between aa#140 and 146. Our data suggest that emergence of these HBV S gene mutants in the phase of HBV vaccination program would be most common among populations in whom perinatal/vertical transmission of HBV is most common, i.e. southeast Asian and the Taiwanese.
    Schlagwörter Immune escape mutants ; Transmission ; Hepatitis B virus ; Hepatitis B surface antigen ; Quasispecies ; Vaccine
    Sprache Englisch
    Erscheinungsdatum 1998-10-09
    Verlag S. Karger AG
    Erscheinungsort Basel, Switzerland
    Dokumenttyp Artikel
    Anmerkung Original Paper
    ZDB-ID 1193378-1
    ISSN 1423-0127 ; 1021-7770
    ISSN (online) 1423-0127
    ISSN 1021-7770
    DOI 10.1159/000025349
    Datenquelle Karger Verlag

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang